Home

Baker Bros. Advisors reported a 3.4% stake in Edgewise Therapeutics EWTX · 3,701,719 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
3.4%
Last report
6.9% · filed 25/08/14
Shares held
3,701,719 sh
Class
Common Stock, par value $0.0001 per share
Event date
26/06/30
Filed
26/08/14

3.4% stake · below 5%

Stake
3.4%
Last report
6.9%
Since last report
−3.5pp

Edgewise Therapeutics trades, last 26 weeks

What else happened in Edgewise Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Baker Bros. Advisors's other 5% stake reports

  • Baker Bros. Advisors

    5% stakeKodiak Sciences

    35% stake

    Filed 09/30

  • Baker Bros. Advisors

    5% stakeBeOne Medicines

    7.8% stake

    Filed 09/16

  • Baker Bros. Advisors

    5% stakeIdeaya Biosciences

    5.2% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeRevolution Medicines

    5.3% stake

    Filed 08/14

  • Baker Bros. Advisors

    5% stakeImmatics

    7% stake

    Filed 08/14